Chartwell Investment Partners, LLC Clovis Oncology, Inc. Transaction History

Chartwell Investment Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 09, 2018	SELL	$42.06 - $62.4 $2.16 Million - $3.21 Million	-51,377 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$57.69 - $84.58 $792,429 - $1.16 Million	-13,736 Reduced 21.1%	51,377 $3.49 Million
Q3 2017 Nov 08, 2017	BUY	$67.17 - $84.81 $4.37 Million - $5.52 Million	65,113	65,113 $5.37 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.